Glyminox Biosyn.
作者信息
Witherell Gary W
机构信息
Questor Pharmaceuticals Inc, 3260 Whipple Road, Union City, CA 94587, USA.
出版信息
Curr Opin Investig Drugs. 2004 Feb;5(2):222-31.
PMID:15043398
Abstract
Glyminox (Savvy) is a vaginal gel formulation of C31G being developed by Biosyn as a potential contraceptive and for the potential prevention of transmission of sexually transmitted diseases, including HIV infection. In March 2002, glyminox was in phase II/III trials for Chlamydia treatment and as a contraceptive, and in phase II trials for herpes simplex virus shedding.
摘要
相似文献
1
Glyminox Biosyn.
Curr Opin Investig Drugs. 2004 Feb;5(2):222-31.
2
PRO-2000, an antimicrobial gel for the potential prevention of HIV infection.PRO - 2000，一种有望预防HIV感染的抗菌凝胶。
Curr Opin Investig Drugs. 2008 Feb;9(2):189-200.
3
Desired qualities and hypothetical contextual use of vaginal microbicides in a diverse sample of US women.美国不同女性样本中阴道杀微生物剂的理想特性及假设的情境使用情况。
Contraception. 2007 Oct;76(4):314-8. doi: 10.1016/j.contraception.2007.05.092. Epub 2007 Aug 28.
4
"We have our protector": misperceptions of protection against HIV among participants in a microbicide efficacy trial.“我们有了保护措施”：在一项杀微生物剂功效试验中参与者对预防艾滋病病毒的误解
Am J Public Health. 2006 Jun;96(6):1073-7. doi: 10.2105/AJPH.2004.047514. Epub 2006 May 2.
5
Vaginal contraceptives. Effective protection from sexually transmitted diseases for women?
J Reprod Med. 1988 Mar;33(3):307-11.
6
AIDSVAX VaxGen.
Curr Opin Investig Drugs. 2004 Feb;5(2):214-21.
7
[Benzalkonium in local contraception and sexually-transmitted diseases].
Ann Ostet Ginecol Med Perinat. 1990 Jul-Aug;111(4):265-9.
8
ONO-2506. Ono.
Curr Opin Investig Drugs. 2003 Jul;4(7):863-7.
9
109881 Aventis.
Curr Opin Investig Drugs. 2003 Jun;4(6):737-40.
10
Easing the way to safer sex.
Lancet. 1998 Mar 28;351(9107):964. doi: 10.1016/S0140-6736(05)60627-7.
Zotero 插件